RMAM
LLY icon

Raab & Moskowitz Asset Management’s Eli Lilly LLY Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24K Buy
+800
New +$817K ﹤0.01% 197

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raab & Moskowitz Asset Management's LLY Position: Q2 2026 in Review

Raab & Moskowitz Asset Management reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2026, selling an estimated $41.9K and leaving 1,809 shares worth $2.17M. The position accounts for 0.44% of the portfolio, ranked #59.

Raab & Moskowitz Asset Management first reported a position in LLY in Q4 2013 and has held it in 31 quarters since. The position peaked at $2.72M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Raab & Moskowitz Asset Management held 1,809 shares of Eli Lilly worth $2.17M as of Q2 2026.
  • Raab & Moskowitz Asset Management sold 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 0.44% of Raab & Moskowitz Asset Management's portfolio in Q2 2026, its #59 holding.
  • Raab & Moskowitz Asset Management first reported a position in Eli Lilly in Q4 2013 and has held it in 31 quarters since.
  • Raab & Moskowitz Asset Management's Eli Lilly position peaked at $2.72M in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.